Safety and clinical efficacy outcomes from the Long-term extension study of tolebrutinib in patients with relapsing multiple sclerosis: 2-year results

被引：0
|
作者：
Oh, J. [1 ]
Syed, S. [2 ]
Orogun, L. [2 ]
Xu, Z. [3 ]
Turner, T. J. [2 ]
Fox, R. J. [4 ]
机构：
[1] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada
[2] Sanofi, Cambridge, MA USA
[3] Sanofi, Bridgewater, MA USA
[4] Cleveland Clin, Mellen Ctr Multiple Sclerosis, Cleveland, OH USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P308
引用
收藏
页码：342 / 343
页数：2
相关论文
共 50 条
  • [41] LONG-TERM SAFETY AND EFFICACY OF SER120 1.5 MCG IN PATIENTS WITH NOCTURIA: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY
    MacDiarmid, Scott
    Nicandro, J. P.
    Cheng, Maria
    Abrams, Steven
    Fein, Seymour
    Wein, Alan
    JOURNAL OF UROLOGY, 2017, 197 (04): : E398 - E398
  • [42] Long-term safety and efficacy of intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis type II: 2-year results from a phase 2/3 extension study
    Muenzer, Joseph
    Burton, Barbara K.
    Harmatz, Paul
    Gonzalez Gutierrez-Solana, Luis
    Ruiz-Garcia, Matilde
    Jones, Simon A.
    Guffon, Nathalie
    Inbar-Feigenberg, Michal
    Bratkovic, Drago
    Li, Xiaoxi
    Yee, Karen S.
    Alexanderian, David
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S73 - S74
  • [43] Long-Term Efficacy, Safety and Tolerability of Ponesimod in Patients with Relapsing-Remitting Multiple Sclerosis
    Freedman, Mark
    Boster, Aaron
    Fernandez, Oscar
    Melanson, Maria
    Pozzilli, Carlo
    D'Ambrosio, Daniele
    Sidorenko, Tatiana
    Olsson, Tomas
    NEUROLOGY, 2013, 80
  • [44] Ponesimod in Relapsing Forms of Multiple Sclerosis - Long-Term Pooled Safety Results from the Clinical Development Program
    Rosas-Ballina, M.
    Wooller, A.
    Walter, V.
    Ait-Tihyaty, M.
    Vaclavkova, A.
    Pozzilli, C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 57 - 57
  • [45] Efficacy and Safety of Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Results from the Phase 3 GEMINI 1 and 2 Trials
    Oh, Jiwon
    Arnold, Douglas L.
    Cree, Bruce A. C.
    Ionete, Carolina
    Kim, Ho Jin
    Sormani, Maria Pia
    Syed, Sana
    Chen, Yixin
    Maxwell, Christina
    Benoit, Patrick
    Turner, Timothy J.
    Wallstroem, Erik
    Wiendl, Heinz
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1145 - 1146
  • [46] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: interim analysis of the DAYBREAK open-label extension study
    Selmaj, K. W.
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, E. K.
    Krakovich, A.
    Sheffield, J. K.
    Cheng, C. -Y.
    Minton, N.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 359 - 360
  • [47] Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: interim analysis of the DAYBREAK open-label extension study
    Selmaj, K. W.
    Steinman, L.
    Comi, G.
    Bar-Or, A.
    Arnold, D. L.
    Hartung, H. -P.
    Montalban, X.
    Havrdova, K.
    Hoogerheyde, J.
    Afsari, S.
    Sheffield, J. K.
    Shi, F.
    Minton, N.
    Silva, D.
    Kappos, L.
    Cohen, J. A.
    Cree, B. A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 617 - 618
  • [48] Long-Term Efficacy and Safety of Fingolimod (FTY720) in Relapsing-Remitting Multiple Sclerosis (RRMS): Results from the Extension of the Phase III FREEDOMS Study
    Kappos, Ludwig
    Radue, Ernst-Wilhelm
    O'Connor, Paul
    Polman, Chris
    Hohlfeld, Reinhard
    Calabresi, Peter
    Selmaj, Krzysztof
    Agoropoulou, Catherine
    Jin, James
    Zhang-Auberson, Lixin
    Francis, Gordon
    NEUROLOGY, 2012, 78
  • [49] LONG-TERM EFFICACY OF OCRELIZUMAB IN RELAPSING MULTIPLE SCLEROSIS
    Giovannoni, Gavin
    Hauser, Stephen L.
    Brochet, Bruno
    Montalban, Xavier
    Naismith, Robert T.
    Wolinsky, Jerry S.
    Hubeaux, Stanislas
    Mehta, Lahar
    Model, Fabian
    Kappos, Ludwig
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E56 - E56
  • [50] Interim Analysis of a Phase III Long Term Extension Study of Ponesimod in Relapsing Multiple Sclerosis: Safety Results
    Rosas-Ballina, M.
    Wooller, A.
    Larbalestier, A.
    Ait-Tihyaty, M.
    Vaclavkova, A.
    Sidorenko, T.
    Montalban, X.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 292 - 293
12345